The pharma industry warned that if proposed new prescription price guidelines go ahead, drug launches would be delayed and ‘Canadian patients will be deprived of potentially life-saving new medicines.’
The pharma industry claims lower prescription drug prices will mean less access to new medication for Canadians. It’s an old threat that pits profits against patients’ rights to affordable drugs.
OxyContin, an opioid drug heavily marketed by Purdue Pharma, is associated with billions of dollars of health-care costs in Canada related to the opioid crisis.
(AP Photo/Toby Talbot)
The Purdue Pharma settlement is paltry compared to costs of the opioid crisis. Without major changes to pharma industry regulation, there is little reason to think a similar crisis won’t occur again.
Very few medical societies have public policies about how to deal with their interactions with companies.
Voluntary medical societies have important roles in professional education and advocacy for doctors and patients, but there is need for transparency about relationships with pharma and health industry.
FDA approval of Pfizer’s COVID-19 vaccine may boost vaccination rates among those who have been hesitant to get the shot.
(AP Photo/Jessica Hill)
The U.S. FDA has approved the first COVID-19 vaccine. How is approval different from emergency use authorization, and what difference will it make to a vaccine that’s already in global use?
A sign board in Toronto’s financial district shows the Toronto Stock Exchange’s market value and gain.
THE CANADIAN PRESS/Frank Gunn
Why are so many entrepreneurs in Canada avoiding going public, and what are the consequences for our economy?